| ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics J Gal, L Kuang, KR Barnett, BZ Zhu, SC Shissler, KV Korotkov, ... Acta neuropathologica 132, 563-576, 2016 | 106 | 2016 |
| HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation J Gal, J Chen, KR Barnett, L Yang, E Brumley, H Zhu Journal of Biological Chemistry 288 (21), 15035-15045, 2013 | 74 | 2013 |
| The acetylation of lysine-376 of G3BP1 regulates RNA binding and stress granule dynamics J Gal, J Chen, DY Na, L Tichacek, KR Barnett, H Zhu Molecular and cellular biology 39 (22), e00052-19, 2019 | 71 | 2019 |
| ATAC-Me captures prolonged DNA methylation of dynamic chromatin accessibility loci during cell fate transitions KR Barnett, BE Decato, TJ Scott, TJ Hansen, B Chen, J Attalla, AD Smith, ... Molecular cell 77 (6), 1350-1364. e6, 2020 | 66 | 2020 |
| Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS A Arenas, J Chen, L Kuang, KR Barnett, EJ Kasarskis, J Gal, H Zhu Human Molecular Genetics 29 (16), 2684-2697, 2020 | 49 | 2020 |
| Human SMARCA5 is continuously required to maintain nucleosome spacing ML Bomber, J Wang, Q Liu, KR Barnett, HM Layden, E Hodges, ... Molecular cell 83 (4), 507-522. e6, 2023 | 30 | 2023 |
| Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development KR Stengel, KR Barnett, J Wang, Q Liu, E Hodges, SW Hiebert, ... Proceedings of the National Academy of Sciences 114 (32), 8608-8613, 2017 | 26 | 2017 |
| Dual detection of chromatin accessibility and DNA methylation using ATAC-Me LN Guerin, KR Barnett, E Hodges Nature protocols 16 (12), 5377-5397, 2021 | 15 | 2021 |
| Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia X Zhao, P Wang, JD Diedrich, B Smart, N Reyes, S Yoshimura, J Zhang, ... Nature communications 13 (1), 5401, 2022 | 13 | 2022 |
| Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia DC Ferguson, JR McCorkle, KR Barnett, EJ Bonten, BP Bergeron, ... Blood Advances 6 (11), 3386-3397, 2022 | 11 | 2022 |
| Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia BP Bergeron, JD Diedrich, Y Zhang, KR Barnett, Q Dong, DC Ferguson, ... Leukemia 36 (10), 2374-2383, 2022 | 10 | 2022 |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators KR Barnett, RJ Mobley, JD Diedrich, BP Bergeron, KR Bhattarai, ... Cell Genomics 3 (12), 2023 | 8 | 2023 |
| Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures KR Barnett, RJ Mobley, JD Diedrich, BP Bergeron, KR Bhattarai, W Yang, ... bioRxiv, 2023 | 4 | 2023 |
| Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma M Hultcrantz, H Hassoun, N Korde, K Maclachlan, S Mailankody, D Patel, ... Blood Cancer Journal 14 (1), 164, 2024 | 2 | 2024 |
| Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia BP Bergeron, KR Barnett, KR Bhattarai, RJ Mobley, BS Hansen, A Brown, ... Blood Advances 7 (15), 4107-4111, 2023 | 2 | 2023 |
| Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment KR Bhattarai, RJ Mobley, KR Barnett, DC Ferguson, BS Hansen, ... Nature communications 15 (1), 3681, 2024 | 1 | 2024 |
| EBF1 Activity Controls Leukemia Sensitivity to Inotuzumab Ozogamicin CS Escherich, Z Li, KR Barnett, Y Li, M Walker, W Yang, X Huang, J Yu, ... Blood 144, 830, 2024 | | 2024 |
| ETS1 Recruits the Canonical Baf Complex to Reactivate the Hematopoietic Stem Cell MYB Enhancer in the T-Cell Leukemia Context C Mullin, KH Lin, A McCarter, E Choe, S Liang, Q Wang, A Melnick, ... Blood 144, 203, 2024 | | 2024 |
| Belantamab Mafodotin, nirogacestat and Pomalidomide for Patients with Relapsed/Refractory Multiple Myeloma M Hultcrantz, H Hassoun, CR Tan, N Korde, AM Lesokhin, H Hashmi, ... Blood 144, 7077, 2024 | | 2024 |
| Crispri Essentiality Screen Reveals the Essential Enhancers and Oncogenes Comprising the “Regulome” of the Notch-Collaborating Transcription Factor ETS1 in Human T-ALL KH Lin, A Wang, K Lashbrook, K Chan, E Choe, A Iyer, KR Barnett, ... Blood 144, 4131, 2024 | | 2024 |
